Trademark: 79180543
Word
MEDICODOSE SYSTEMS 3C SOLUTION COMPLIANCE COUNTERFEIT CLINICAL TRIALS
Status Date
Friday, July 21, 2023
Registration Number
5116462
Registration Date
Tuesday, January 10, 2017
Filing Date
Friday, May 29, 2015
Published for Opposition
Tuesday, October 25, 2016
Cancellation Date
Friday, July 21, 2023
9 Scientific apparatuses and instruments for recording and processing information and programs for computers, namely, data processors; monitors for monitoring and tracking the administration of medicines, namely, electronic and computer apparatus in the nature of embedded firmware for monitoring, tracking and recording the administration of medicines; ; data processing equipment and Computer software for use in database management, integrated circuit cards as smart cards; electronic equipment for compilation of medical data by means of wired or wireless transfer of information relating to packaging of medicine intended for personal computers or other data processing equipment, namely, smart phones, computer software platform; electronic reading units, namely, scanners and readers ; Interfaces for computers; computer software for use with packaging equipped with electronic data storage, data storage units and/or display of data, namely, data related to medication intake dosing histories ; software for processing data compiled from packaging with electronic memory and data storage units; ; electronic devices for the detection of counterfeiting, namely, pharmaceutical packaging containing embedded software; integrated circuit cards as smart cards, detection labels and multi-way data recording; scanners and readers for reading and downloading data recorded by circuit cards or identification tags by near field communication (NFC) and radio frequency Identification; computer software for integrated circuit cards smart cards, sensing tags and related scanners and readers for reading and scanning pharmaceutical packaging; software for receiving, retrieval and/or display of data analysis events, in particular in connection with diagnostic and medical information
5 Veterinary products and medicines, namely, Anti-infective products for the treatment of infection diseases and conditions; dietetic substances for medical use, namely, dietetic sugar for medical use, chemical preparations for pharmaceutical or medical use, namely, the antiseptic preparations and disinfectants for hygiene purposes
16 Packaging for pharmaceutical and healthcare products in the nature of cardboard, cardboard and plastic materials combined namely polyethylene and or aluminum, or plastic, including packaging fitted with electronic memory, data storage units and data display units; polyethylene or aluminum for packaging including plastic flexible packaging films used with electronic data storage and data display units, namely, cardboard and plastic bags, sachets, boxes and blister packs; Paper board or paper for the packaging of pharmaceutical products and medicines; Secondary packaging in the nature of cardboard boxes, blister packs for pharmaceutical preparations and medicines in paper and plastic; plastic materials for packaging namely, thermoformed pharmaceutical grade plastic in the nature of plastic bags, containers and film for packaging made of Polypropylene, Polyvinylchloride, Polychlorotrifluoroethylene, Cyclic olefin copolymers, Cyclic olefin polymers and Ethylene-Vinyl Alcohol; products made from the aforesaid materials, namely, blister packs for use as medicines packaging
38 electronic data transmission for using voice services, SMS short message services and data over local and global computer networks; providing multiple-user access to on-line electronic bulletin boards for transmission of messages among computer users relating to medical matters; providing access to a website, namely, the internet that enables users to log on into the website to create information and reports on health, well-being; providing access to web sites for internet users to create technology, annotate, manage and/or utilize information relating to health and well-being; providing access in the nature of, transmission of information data for monitoring and follow-up on medicine intake and reports from electronic questionnaires related to clinical outcomes over a computer network; communications by computer terminals or by fiber-optic networks; radio or telephone communications, mobile radio-telephony services; on-line or telephone reminder services on taking and renewing medication; provision of on-line forums related to clinical indications and medicines; providing access to databases in the medical field; electronic bulletin board services; providing internet users with access rights to dedicated medical databases and web site to create, annotate, manage and/or use data relating to their health, compliance monitoring and detecting counterfeit medicines; providing electronic transmission of patient medical information via the internet; Computer aided transmission of medical information recorded in a database; Computer aided transmission of expert medical reports via electronic means, web site or email
35 Market research and analysis in the field of pharmaceuticals; promotion of goods and communication services for the pharmaceutical industry in the nature of wired or wireless electronic monitoring and digital mobile networks applied to telemedicine and eHealth care services through dedicated websites and databases; Pharmaceutical business evaluation of information from data tracking use of medication and electronic questionnaires relating to medication intake and effects of medicines through data compilation, preparation of clinical reports relating thereto; analysis of market statistics, compiling information from these statistics and reports containing such information into dedicated databases; computerized file management; commercial information and marketing for third parties, namely, pharmaceutical industry
44 Consulting relating to medical monitoring of the consumption of various medicines; medical information services, namely, information concerning medication intake, medication dosage, allergic sensitivity, medication interactions, clinic appointments and renewing prescriptions, intended for patients and provided by means of alerts and interactive monitoring through telephone, email, SMS, website and mobile applications; medical advisory and consultancy services in the field of health; medical advice relating to the best way to ensure medicine is taken correctly and on time; medical information services in the field of health for third parties
21 Pill boxes, not included in other classes for personal use; medicine dispensers, namely, solid form medicines dispensers, for pharmaceutical or household purposes not included in other classes; pill boxes for personal use
20 Containers plastic for packaging; boxes and containers of plastic for packaging of pharmaceutical preparations and medicines, including containers with electronic data storage, data storage units and/or display of data; non-metallic containers for packaging medicines that help a patient follow a medical treatment, collect data on the contents of the medicines in the container and communicate with a remote server; plastic packaging containers combined with polyethylene with addition of aluminum and plastic
The mark consists of three stylized "C's" in color; the first is red, the second is green, the third is blue; Following the words: "MEDICODOSE SYSTEMS" and "3C SOLUTION" in black; the word "COMPLIANCE" in red, the word "COUNTERFEIT" in green and the words "CLINICAL TRIALS" in blue.
MEDICODOSE SYSTEMS THREE C SOLUTION COMPLIANCE COUNTERFEIT CLINICAL TRIALS
The color(s) red, black, green and blue is/are claimed as a feature of the mark.
"SYSTEMS" "COMPLIANCE COUNTERFEIT CLINICAL TRIALS"
Apr 3, 2024
Generic Madrid Transaction Sent To Ib
Apr 2, 2024
Generic Madrid Transaction Created
Mar 21, 2024
Total Invalidation Of Reg Ext Protection Created
Jul 21, 2023
Cancelled Section 71
Jan 10, 2022
Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed
Sep 8, 2017
Final Decision Transaction Processed By Ib
Apr 12, 2017
Generic Madrid Transaction Sent To Ib
Apr 11, 2017
Generic Madrid Transaction Created
Apr 10, 2017
Final Disposition Notice Created, To Be Sent To Ib
Mar 16, 2017
Change Of Name/Address Rec'd From Ib
Jan 10, 2017
Registered-Principal Register
Dec 9, 2016
Notification Of Possible Opposition - Processed By Ib
Oct 25, 2016
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2016
Published For Opposition
Oct 5, 2016
Notification Of Possible Opposition Sent To Ib
Oct 5, 2016
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 5, 2016
Notification Of Notice Of Publication E-Mailed
Sep 20, 2016
Approved For Pub - Principal Register
Aug 26, 2016
Teas/Email Correspondence Entered
Aug 26, 2016
Correspondence Received In Law Office
Aug 26, 2016
Teas Request For Reconsideration Received
Aug 13, 2016
Notification Of Final Refusal Emailed
Aug 13, 2016
Final Refusal E-Mailed
Aug 13, 2016
Final Refusal Written
Jul 20, 2016
Teas/Email Correspondence Entered
Jul 20, 2016
Correspondence Received In Law Office
Jul 20, 2016
Teas Response To Office Action Received
Jul 20, 2016
Teas Change Of Correspondence Received
Feb 13, 2016
Refusal Processed By Ib
Jan 22, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Jan 22, 2016
Refusal Processed By Mpu
Jan 21, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Jan 20, 2016
Non-Final Action Written
Jan 19, 2016
Application Filing Receipt Mailed
Jan 15, 2016
Assigned To Examiner
Jan 15, 2016
New Application Office Supplied Data Entered
Jan 14, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
